TwinBeech Capital’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-36,022
Closed -$5.49M 504
2024
Q1
$5.49M Buy
36,022
+29,271
+434% +$4.87M 0.11% 195
2023
Q4
$2.12M Buy
+6,751
New +$2.44M 0.03% 393
2023
Q3
Sell
-30,873
Closed -$13.4M 619
2023
Q2
$13.4M Buy
+30,873
New +$17.4M 0.26% 120
2021
Q4
Sell
-1,466
Closed -$961K 541
2021
Q3
$961K Buy
+1,466
New +$1.25M 0.07% 331

Other funds holding AGL

TwinBeech Capital's AGL Position: Q2 2024 in Review

TwinBeech Capital sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 36,022 shares — an estimated $5.49M sold.

TwinBeech Capital first reported a position in AGL in Q3 2021 and held it in 4 quarters. The position peaked at $13.4M in Q2 2023. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • TwinBeech Capital reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • TwinBeech Capital sold 36,022 Agilon Health shares in Q2 2024, an estimated $5.49M.
  • TwinBeech Capital first reported a position in Agilon Health in Q3 2021 and held it in 4 quarters.
  • TwinBeech Capital's Agilon Health position peaked at $13.4M in Q2 2023.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on TwinBeech Capital's 13F filing for Q2 2024, filed 14 Aug 2024.